share_log

HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $34 Price Target

HC Wainwright & Co. Reiterates Buy on Checkpoint Therapeutics, Maintains $34 Price Target

HC Wainwright & Co.重申買入Checkpoint Therapeutics,維持34美元的目標股價
Benzinga ·  05/16 11:38

HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $34 price target.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯重申Checkpoint Therapeutics(納斯達克股票代碼:CKPT)的買入並維持34美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論